These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24414483)

  • 21. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer.
    Jiao L; Hassan MM; Bondy ML; Wolff RA; Evans DB; Abbruzzese JL; Li D
    Am J Gastroenterol; 2008 Feb; 103(2):360-7. PubMed ID: 17986315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer.
    Smolarz B; Michalska MM; Samulak D; Romanowicz H; Wójcik L
    Pathol Oncol Res; 2019 Oct; 25(4):1607-1614. PubMed ID: 30712190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.
    Du L; Liu Y; Xue P; Song C; Shen J; He Q; Peng Y; Tong X; Tang L; Zhang Y
    Tumour Biol; 2015 Jun; 36(6):4545-54. PubMed ID: 25619474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p73 G4C14-A4T14 polymorphism and cancer risk: a meta-analysis based on 27 case-control studies.
    Liu F; Liu L; Li B; Wei YG; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
    Mutagenesis; 2011 Jul; 26(4):573-81. PubMed ID: 21502193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The G894t, T-786c and 4b/a polymorphisms in Enos gene and cancer risk: a meta-analysis.
    Zhang L; Chen LM; Wang MN; Chen XJ; Li N; Huang YD; Chen M
    J Evid Based Med; 2014 Dec; 7(4):263-9. PubMed ID: 25586457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis.
    Zhang J; Zeng XT; Lei JR; Tang YJ; Yang J
    Tumour Biol; 2014 Jun; 35(6):5629-35. PubMed ID: 24590265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: an update by meta-analysis of 53 individual studies.
    Zhang K; Zhou B; Wang Y; Rao L; Zhang L
    Gene; 2012 Dec; 510(2):93-101. PubMed ID: 22975644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
    Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ
    PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Val158Met polymorphism in the COMT gene is associated with increased cancer risks in Chinese population.
    Tian C; Liu L; Yang X; Wu H; Ouyang Q
    Tumour Biol; 2014 Apr; 35(4):3003-8. PubMed ID: 24307619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between the poly(A) polymorphism in the VDR gene and cancer risk: a meta-analysis.
    Huang J; Yang J; Wang H; Xiong T; Zhang H; Ma Y; Wang X; Huang J; Du L
    Tumour Biol; 2013 Jun; 34(3):1833-8. PubMed ID: 23519839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between the Arg280His polymorphism in the XRCC1 gene and the risk of hematological malignancies.
    Tong X; Yang J; Peng Y; Shen J; Xiong T; Zhang Y; Fan H
    Tumour Biol; 2014 Feb; 35(2):1687-93. PubMed ID: 24096581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphisms of RAD51 G135C, XRCC2 Arg188His and XRCC3 Thr241Met homologous recombination repair genes and the risk of sporadic endometrial cancer in Polish women.
    Romanowicz-Makowska H; Smolarz B; Połać I; Sporny S
    J Obstet Gynaecol Res; 2012 Jun; 38(6):918-24. PubMed ID: 22487057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Kamali M; Hamadani S; Neamatzadeh H; Mazaheri M; Zare Shehneh M; Modaress Gilani M; Haghighi F
    Asian Pac J Cancer Prev; 2017 Jul; 18(7):1743-1749. PubMed ID: 28749098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between ATM polymorphisms and cancer risk: a meta-analysis.
    Shen L; Yin ZH; Wan Y; Zhang Y; Li K; Zhou BS
    Mol Biol Rep; 2012 May; 39(5):5719-25. PubMed ID: 22203481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.
    Huang J; Huang J; Ma Y; Wang H; Yang J; Xiong T; Du L
    Mol Biol Rep; 2013 Jul; 40(7):4219-25. PubMed ID: 23649760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk.
    Jiang H; Lin Y; Yang CQ; Li Q; Luo J; Zhou Y; Xue J; Wei W; Gao Y
    Tumour Biol; 2013 Apr; 34(2):779-85. PubMed ID: 23271361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis.
    Yan YL; Chen X; Liang HJ; Wang J; Li TJ; Li RL; Li S; Qin X
    Dis Esophagus; 2015; 28(2):164-71. PubMed ID: 25714851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
    Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
    Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.